We show that in contrast to the CB1 mRNA expression, which was comparable in all studied cells and normal human astrocytes, CB2 mRNA was detected primarily in cells originated from glioblastomas, while low or undetectable levels of CB2 mRNA were observed in NHA and some astrocytoma-derived cell lines. This evidence concerns the gene CNR1 and glioblastoma.